.
Midcap Pharma stock reaches 52 week low; Brokerage sees 34% upside

Midcap Pharma stock reaches 52 week low; Brokerage sees 34% upside

Sanofi India Ltd’s share price took a beating in response to litigation threats and a cancer drug development setback. The finance chief of the pharmaceutical company said on Wednesday that a decline was strongly exaggerated and posed a buying opportunity for savvy investors. Sanofi India is engaged in the business of manufacturing and sale of [...]
×